SEC Form 4 · accession 0001562180-16-002626
Intersect ENT, Inc. · XENT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James Stambaugh
Officer — VP Clinical Affairs
Period of report
Jun 13, 2016
Accepted (ET)
Jun 14, 2016 · 4:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001271214
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jun 13, 2016 | S | 500 | $14.3821 | D | 24,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.3801 to $14.385, inclusive. The Reporting Person undertakes to provide, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote on this Form 4.
- F2Includes the acquisition of 500 shares under the Intersect ENT, Inc. 2014 Employee Stock Purchase Plan on May 13, 2016.